Sterling Capital Management’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.22K Sell
56
-153
-73% -$3.33K ﹤0.01% 3030
2025
Q1
$3.86K Sell
209
-164
-44% -$3.03K ﹤0.01% 2288
2024
Q4
$9.94K Buy
373
+314
+532% +$8.37K ﹤0.01% 2165
2024
Q3
$1.39K Buy
+59
New +$1.39K ﹤0.01% 2373